References
- Mann K, Fox SP, Abbs SJ, Yau SC, Scriven PN, Dcherty Z, Ogilvie CM. Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis. Lancet 2001;358:1057–1061.
- Tepperberg J, Pettenati MJ, Rao PN, Lese CM, Rita D, Wyandt H, Gersen S, White B, Schoonmaker MM. Prenatal diagnosis using fluorescence in situ hybridisation (FISH): 2‐year multi-centre retrospective study and review of the literature. Prenat Diagn 2001;21:293–301.
- Ryan M, Diack J, Watson V, Smith N. Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women. Prenat Diagn 2005;25:1206–1211.
- Caughey AB, Washington AE, Gildengorin V, Kuppermann M. Assessment of demand for prenatal diagnostic testing using willingness to pay. Obstet Gynecol 2004;103:539–545.
- Rose D, Pevalin D, O'Reilly K. The national statistics socio-economic classification: origins, development and use. London: ONS; 2005.
- Leung WC, Lau ET, Lao TT, Tang MHY. Can amnio-polymerase chain reaction alone replace conventional cytogenetic study for women with positive biochemical screening for fetal Down syndrome? Obstet Gynecol 2003;101:856–861.
- Cederholm M, Axelsson O, Sjoden P-O. Women's knowledge, concerns and psychological reactions before undergoing an invasive procedure for prenatal karyotyping. Ultrasound Obstet Gynecol 1999;14:267–272.
- Leung WC, Lau ET, Ngai C, Lam H, Leung KY, Lee CP, Lao TT, Tang MH. A prospective study on the effect of rapid aneuploidy testing (Amnio-PCR) on anxiety levels and quality of life measures in women and their partners with positive Down screening result. Fetal Diagn Ther 2008;24:165–169.